Jason A. Keyes

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul Lytle, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jason A. Keyes

Form 4 holding Chief Financial Officer

Equillium, Inc.

Security class
Common Stock
Shares / value
88,913
Estimated value
$57,793
Report date
23 Jan 2025
Price
$0.6500
Ownership
Direct
Form 4 holding Chief Financial Officer

Equillium, Inc.

Security class
Common Stock
Shares / value
37,720
Estimated value
$24,518
Report date
23 Jan 2025
Price
$0.6500
Ownership
By The Keyes Trust Dated September 10, 2004
Form 4 holding Director

Sesen Bio, Inc.

Security class
Common Stock
Shares / value
40,000
Estimated value
$23,480
Report date
22 Jun 2022
Price
$0.5870
Ownership
Direct
Form 4 holding Director

Sesen Bio, Inc.

Security class
Stock Option
Shares / value
65,000
Estimated value
Report date
22 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ACTUATE THERAPEUTICS, INC.

Security class
Non-Qualified Stock Options
Shares / value
30,000
Estimated value
Report date
12 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Equillium, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
14 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jason A. Keyes

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .